This bill proposes significant updates to the current statutes regarding the administration of abortion-inducing drugs. Under the new provisions, a qualified physician must conduct an in-person examination of the patient before providing the drug, which includes verifying pregnancy, determining blood type, informing the patient of potential side effects, and documenting specific medical details in the patient's chart. Additionally, the physician must be credentialed to manage complications or have a signed agreement with another qualified physician. Follow-up appointments are mandated to confirm the termination of pregnancy and assess bleeding, with documentation of efforts to ensure patient compliance required in the medical record.

The bill also introduces a civil right of action for individuals who suffer from intentional or knowing violations of these requirements. This includes claims from the woman receiving the drug, a minor's parent or guardian, and the father of the unborn child under certain conditions. The civil action must be filed in the superior court of the woman's residence, and relief can include monetary damages, statutory damages, and attorney fees. Furthermore, the bill emphasizes confidentiality for the identity of women involved in such actions, requiring pseudonyms unless consent is given, and it explicitly states that it does not create or recognize a right to abortion.

Statutes affected:
Introduced Version: 36-2160
House Engrossed Version: 36-2160